Apellis Pharmaceuticals Inc. (APLS)

Apellis Pharmaceuticals Inc. (APLS $19.28)
- $19.28 Cap: $2.43B
- View APLS Profile
- View Questions on APLS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Apellis Pharmaceuticals Inc. (APLS $19.28)
- $19.28 Cap: $2.43B
- View APLS Profile
- View Questions on APLS

Q: There has been a precipitous drop in APLS in the last few days. Any news on the reasons and the prospects for the future.

Thanks

Thomas

Read Answer Asked by Thomas on October 01, 2024

Apellis Pharmaceuticals Inc. (APLS $19.28)
- $19.28 Cap: $2.43B
- View APLS Profile
- View Questions on APLS

Q: APLS.US has had a down turn recently. Will it recover or are there some intrinsic problems with the company.

Thanks

Thomas

Read Answer Asked by Thomas on July 03, 2024

Apellis Pharmaceuticals Inc. (APLS $19.28)
- $19.28 Cap: $2.43B
- View APLS Profile
- View Questions on APLS

Q: I would like your opinion on Apellis Pharmaceuticals. I read Citron's research piece (was published in November) on this company new product -Syfovre- issues and make a little bit of research myself. Obviously Citron is mostly promotting its own short positions but this one seems a reasonnable bet considering the content of the report (see attached link). No warning letter yet by the FDA but it is surely a real possibility.

Thank you!

Michel C

https://citronresearch.com/wp-content/uploads/2023/11/Citron-Reports-on-Apellis-Pharmaceuticals.pdf

Read Answer Asked by Michel on January 08, 2024